What Are the Signs of a Sarcoidosis Flare-Up?
At a Glance
A sarcoidosis flare-up involves active, new inflammation causing distinctly worsening symptoms like severe shortness of breath, profound fatigue, fevers, or new skin and eye lesions. Unlike stable chronic symptoms, a flare-up requires medical evaluation to prevent organ damage.
In this answer
3 sections
Living with sarcoidosis often means navigating daily chronic symptoms, but a true flare-up (exacerbation) is different: it indicates active, new inflammation that requires your doctor’s attention. While a “bad day” might involve your usual level of lingering fatigue or stable shortness of breath, a flare-up typically brings a distinct worsening of your respiratory symptoms, the return of profound exhaustion, new skin lesions, or systemic signs like fever and night sweats [1][2]. Recognizing the difference empowers you to seek medical care when it is truly needed.
Chronic Symptoms vs. Active Flare-Ups
Because sarcoidosis can cause long-term structural changes or scarring in the body, many patients experience chronic symptoms even when the disease is not actively inflamed [1]. Chronic symptoms are generally stable day-to-day.
An exacerbation, or flare-up, means your immune system is actively forming new granulomas (tiny clumps of inflammatory cells) [2]. Because a flare-up can threaten organ function, your doctor will want to evaluate new symptoms to decide if your treatment plan needs adjusting [1][3].
Clinical Signs of a Flare-Up
A flare-up can manifest in the lungs (where sarcoidosis most commonly strikes) or throughout the rest of the body. Key clinical signs that you may be experiencing a flare include:
- Worsening respiratory symptoms: A noticeable increase in your cough or new, worsening dyspnea (shortness of breath) during activities that you could previously handle [1][4].
- Systemic symptoms: The return of profound, debilitating fatigue, accompanied by unexplained fevers, night sweats, or unintentional weight loss [1][2].
- Skin and joint changes: The appearance of new skin lesions (such as painful bumps on your shins, raised plaques, or changes in old scars) [5][6], or new, severe joint pain (polyarthritis) [7][8].
- Eye changes: Sarcoidosis frequently causes ocular inflammation (such as uveitis) [9]. New eye pain, severe redness, light sensitivity, or blurry vision are signs of a flare-up that require rapid medical evaluation to prevent irreversible vision loss.
⚠️ Warning: Seek Emergency Care
If you experience new neurological symptoms (like severe headaches, facial weakness, or numbness) [1][4] or cardiac symptoms (like irregular heartbeats, palpitations, chest pain, or fainting spells) [4][10], do not wait for a routine doctor’s appointment. These can indicate life-threatening complications and require immediate emergency medical evaluation.
How Doctors Confirm a Flare-Up
Because symptoms alone can be subjective, doctors rely on objective medical tests to confirm if your sarcoidosis is actively flaring [3].
Pulmonary Function Tests (PFTs)
Your doctor will likely order breathing tests to measure your lung capacity. A significant decline in your FVC (Forced Vital Capacity, the total amount of air you can exhale) or DLCO (how well oxygen moves from your lungs into your blood) is a primary objective marker of clinical deterioration and disease progression [11][12].
Advanced Imaging and Exams
Standard chest X-rays can sometimes miss new inflammation. To get a clearer picture, doctors use:
- Thoracic CT Scans: High-resolution scans can reveal new structural changes or worsening lymph node enlargement [13][14].
- FDG-PET/CT Scans: These highly sensitive scans highlight areas of active glucose metabolism (showing where inflamed cells are using extra energy), pinpointing exactly where active inflammation is occurring in the body [15][16].
- Ophthalmologic Exams: A specialized “slit-lamp” exam by an eye doctor is a standard tool to detect active sarcoidosis in the eyes, even if you haven’t noticed severe vision changes yet [9].
Blood Biomarkers
While blood tests cannot diagnose a flare-up on their own, doctors use them alongside your symptoms and imaging [3][17]. They may look for elevated inflammatory markers like sIL-2R (soluble interleukin-2 receptor) or chitotriosidase, which can indicate active disease [18][19]. Note that while ACE (angiotensin-converting enzyme) levels are often tested, modern research shows they are not always reliable for monitoring disease activity in everyone [20][21].
Actionable Tip: If you suspect a flare-up, keep a brief daily symptom diary tracking the frequency and severity of your symptoms for a few days. Sharing this with your doctor will help them quickly differentiate between normal daily symptom fluctuations and a true exacerbation.
Common questions in this guide
How can I tell the difference between chronic sarcoidosis and a flare-up?
What are the emergency warning signs of a sarcoidosis flare-up?
How do doctors confirm a sarcoidosis exacerbation?
What blood tests show active sarcoidosis inflammation?
When should I contact my doctor about a potential sarcoidosis flare-up?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Tests for flare-ups
Would breathing tests help my doctor check whether a flare-up is happening?
Imaging options
Would an FDG-PET/CT scan help show where inflammation is active?
Eye checks
Should I have a slit-lamp eye exam to check for active sarcoidosis in my eyes?
Related questions
Show more
Get notified when new evidence is published on Sarcoidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (21)
- 1
[Epidemiology and Clinical Presentation of Sarcoidosis].
Costabel U, Wessendorf TE, Bonella F
Klinische Monatsblatter fur Augenheilkunde 2017; (234(6)):790-795 doi:10.1055/s-0042-105569.
PMID: 27454307 - 2
Fatigue syndrome in sarcoidosis.
Górski W, Piotrowski WJ
Pneumonologia i alergologia polska 2016; (84(4)):244-50 doi:10.5603/PiAP.2016.0030.
PMID: 27435351 - 3
BTS Clinical Statement on pulmonary sarcoidosis.
Thillai M, Atkins CP, Crawshaw A, et al.
Thorax 2021; (76(1)):4-20 doi:10.1136/thoraxjnl-2019-214348.
PMID: 33268456 - 4
Cardiac sarcoidosis as an incidental finding: A case report.
Gabaldon-Perez A, Garcia-Blas S, Forner MJ, et al.
Heart & lung : the journal of critical care 2020; (49(6)):783-787 doi:10.1016/j.hrtlng.2020.09.009.
PMID: 32980628 - 5
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial.
Redl A, Doberer K, Unterluggauer L, et al.
The Lancet. Rheumatology 2024; (6(2)):e81-e91 doi:10.1016/S2665-9913(23)00302-8.
PMID: 38267106 - 6
Extrapulmonary sarcoidosis in an atypical patient demographic.
Modi T, Maniam G, Quirch M, et al.
Proceedings (Baylor University. Medical Center) 2020; (34(1)):151-152 doi:10.1080/08998280.2020.1824963.
PMID: 33456182 - 7
Löfgren Syndrome: A Mosaic of Sarcoidosis Phenotypes.
Martins F, Martins M, Malheiro R
Cureus 2024; (16(1)):e52317 doi:10.7759/cureus.52317.
PMID: 38226315 - 8
[Musculoskeletal manifestations of sarcoidosis].
Korsten P, Chehab G
Zeitschrift fur Rheumatologie 2017; (76(5)):408-414 doi:10.1007/s00393-017-0313-5.
PMID: 28488045 - 9
Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
Ishihara M, Meguro A, Ishido M, et al.
Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):2311-2317 doi:10.2147/OPTH.S264595.
PMID: 32848359 - 10
Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis.
Avagimyan A, Mkrtchyan L, Bairamyan T, et al.
ARYA atherosclerosis 2023; (19(5)):52-62 doi:10.48305/arya.2023.41534.2888.
PMID: 38882645 - 11
Lymphocyte Subsets and Pulmonary Nodules to Predict the Progression of Sarcoidosis.
Danila E, Aleksonienė R, Besusparis J, et al.
Biomedicines 2023; (11(5)) doi:10.3390/biomedicines11051437.
PMID: 37239108 - 12
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study.
Martusewicz-Boros MM, Boros PW, Wiatr E, et al.
Medicine 2019; (98(47)):e18037 doi:10.1097/MD.0000000000018037.
PMID: 31764823 - 13
From X-rays to advanced imaging modalities in pulmonary sarcoidosis.
Ledda RE, Roberti C, Sverzellati N
Current opinion in immunology 2025; (98()):102709 doi:10.1016/j.coi.2025.102709.
PMID: 41406556 - 14
Relationship Between Thoracic CT Severity Score and Scadding Staging With PFT, DLCO, and 6MWT in Patients With Sarcoidosis.
Takeş MA, Korkmaz C, Poyraz N, et al.
Canadian respiratory journal 2025; (2025()):1655729 doi:10.1155/carj/1655729.
PMID: 41311681 - 15
Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis.
Donnelly R, McDermott M, McManus G, et al.
European radiology 2025; (35(4)):2222-2232 doi:10.1007/s00330-024-10949-4.
PMID: 39044038 - 16
Systemic sarcoidosis with pituitary adenoma.
Carbone RG, Penna D, Monselise A, Puppo F
Journal of clinical imaging science 2022; (12()):32 doi:10.25259/JCIS_43_2022.
PMID: 35769093 - 17
Biomarkers in sarcoidosis.
Chopra A, Kalkanis A, Judson MA
Expert review of clinical immunology 2016; (12(11)):1191-1208 doi:10.1080/1744666X.2016.1196135.
PMID: 27253883 - 18
YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P, Durmus S, Sozer V, et al.
Biomolecules 2018; (8(3)) doi:10.3390/biom8030084.
PMID: 30154391 - 19
Verifying Sarcoidosis Activity: Chitotriosidase versus ACE in Sarcoidosis - a Case-control Study.
Popević S, Šumarac Z, Jovanović D, et al.
Journal of medical biochemistry 2016; (35(4)):390-400 doi:10.1515/jomb-2016-0017.
PMID: 28670191 - 20
Put Down the ACE: Low Clinical Utility for Angiotensin-Converting Enzyme Levels in Sarcoidosis: A Single-Center Retrospective Cohort Study.
Druyan A, Shuv N, Lidar M
Journal of clinical medicine 2024; (13(24)) doi:10.3390/jcm13247657.
PMID: 39768579 - 21
Role of serum soluble interleukin 2-receptor in the evaluation of myocardial inflammation in patients with cardiac sarcoidosis and ventricular arrhythmias.
Reithmann C, Min S, Kling T, et al.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2022; (65(2)):353-355 doi:10.1007/s10840-022-01271-4.
PMID: 35697889
This page explains the clinical signs of a sarcoidosis flare-up for educational purposes only and does not replace professional medical advice. Always contact your healthcare provider immediately if you experience severe or rapidly worsening symptoms.